Literature DB >> 10200950

Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer.

H van Steeg1, K H Kraemer.   

Abstract

Xeroderma pigmentosum (XP) is a rare, autosomal recessive disease that is characterized by the extreme sensitivity of the skin to sunlight. Compared to normal individuals, XP patients have a more than 1000-fold increased risk of developing cancer on sun-exposed areas of the skin. Genetic and molecular analyses have revealed that the repair of ultraviolet (UV)-induced DNA damage is impaired in XP patients owing to mutations in genes that form part of a DNA-repair pathway known as nucleotide excision repair (NER). Two other diseases, Cockayne syndrome (CS) and the photosensitive form of trichothiodystrophy (TTD), are linked to a defect in the NER pathway. Strikingly, although CS and TTD patients are UV-sensitive, they do not develop skin cancer. The recently developed animal models that mimic the human phenotypes of XP, CS and TTD will contribute to a better understanding of the etiology of these diseases and the role of UV-induced DNA damage in the development of skin cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10200950     DOI: 10.1016/s1357-4310(98)01394-x

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  43 in total

1.  Regulation and disregulation of mammalian nucleotide excision repair: a pathway to nongermline breast carcinogenesis.

Authors:  Jean J Latimer; Vongai J Majekwana; Yashira R Pabón-Padín; Manasi R Pimpley; Stephen G Grant
Journal:  Photochem Photobiol       Date:  2014-12-19       Impact factor: 3.421

2.  Construction and purification of site-specifically modified DNA templates for transcription assays.

Authors:  Rebecca A Perlow; Thomas M Schinecker; Se Jun Kim; Nicholas E Geacintov; David A Scicchitano
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

3.  Structural basis for recruitment of translesion DNA polymerase Pol IV/DinB to the beta-clamp.

Authors:  Karen A Bunting; S Mark Roe; Laurence H Pearl
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

4.  The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.

Authors:  Juhong Liu; Fedor Kouzine; Zuqin Nie; Hye-Jung Chung; Zichrini Elisha-Feil; Achim Weber; Keji Zhao; David Levens
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

5.  The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.

Authors:  Patrick S Lin; Lisa A McPherson; Aubrey Y Chen; Julien Sage; James M Ford
Journal:  DNA Repair (Amst)       Date:  2009-04-18

Review 6.  Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship.

Authors:  K H Kraemer; N J Patronas; R Schiffmann; B P Brooks; D Tamura; J J DiGiovanna
Journal:  Neuroscience       Date:  2007-02-01       Impact factor: 3.590

7.  The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function.

Authors:  Sikandar G Khan; Vanessa Muniz-Medina; Tala Shahlavi; Carl C Baker; Hiroki Inui; Takahiro Ueda; Steffen Emmert; Thomas D Schneider; Kenneth H Kraemer
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

8.  Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation.

Authors:  Paul Talalay; Jed W Fahey; Zachary R Healy; Scott L Wehage; Andrea L Benedict; Christine Min; Albena T Dinkova-Kostova
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

9.  Gene expression profiling of xeroderma pigmentosum.

Authors:  Nikola A Bowden; Paul A Tooney; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857

10.  Both XPD alleles contribute to the phenotype of compound heterozygote xeroderma pigmentosum patients.

Authors:  Takahiro Ueda; Emmanuel Compe; Philippe Catez; Kenneth H Kraemer; Jean-Marc Egly
Journal:  J Exp Med       Date:  2009-11-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.